255 related articles for article (PubMed ID: 24846802)
1. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
[TBL] [Abstract][Full Text] [Related]
2. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage.
Tan Q; Chen Q; Niu Y; Feng Z; Li L; Tao Y; Tang J; Yang L; Guo J; Feng H; Zhu G; Chen Z
J Neurosurg; 2017 Feb; 126(2):548-557. PubMed ID: 27104852
[TBL] [Abstract][Full Text] [Related]
3. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation.
Rohde V; Rohde I; Thiex R; Ince A; Jung A; Dückers G; Gröschel K; Röttger C; Küker W; Müller HD; Gilsbach JM
J Neurosurg; 2002 Oct; 97(4):954-62. PubMed ID: 12405387
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
Wang YC; Lin CW; Shen CC; Lai SC; Kuo JS
J Neurol Sci; 2002 Oct; 202(1-2):35-41. PubMed ID: 12220690
[TBL] [Abstract][Full Text] [Related]
6. Dose effect of intraventricular fibrinolysis in ventricular hemorrhage.
Staykov D; Wagner I; Volbers B; Huttner HB; Doerfler A; Schwab S; Bardutzky J
Stroke; 2011 Jul; 42(7):2061-4. PubMed ID: 21546475
[TBL] [Abstract][Full Text] [Related]
7. Shunt Dependence after Intraventricular Hemorrhage and Intraventricular Fibrinolysis with uPA versus rt-PA.
Covrig RC; Schellinger PD; Glahn J; Alomari A; Schmieder K; Wiese M; Knappe UJ
J Neurol Surg A Cent Eur Neurosurg; 2023 May; 84(3):255-260. PubMed ID: 35100632
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of fibrinolytic properties of Alteplase, Tenecteplase and Urokinase in an in vitro clot model of intracerebral haemorrhage.
Keric N; Döbel M; Krenzlin H; Kurz E; Tanyildizi Y; Heimann A; König J; Kempski O; Ringel F; Masomi-Bornwasser J
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105073. PubMed ID: 32807475
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage.
Tan Q; Chen Q; Feng Z; Shi X; Tang J; Tao Y; Jiang B; Tan L; Feng H; Zhu G; Yang Y; Chen Z
Brain Res; 2017 Jan; 1654(Pt A):24-33. PubMed ID: 27769788
[TBL] [Abstract][Full Text] [Related]
10. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
[TBL] [Abstract][Full Text] [Related]
11. Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement.
Lee ST; Chu K; Jung KH; Kim J; Kim EH; Kim SJ; Sinn DI; Ko SY; Kim M; Roh JK
J Cereb Blood Flow Metab; 2006 Apr; 26(4):536-44. PubMed ID: 16107786
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial.
Kramer AH; Jenne CN; Zygun DA; Roberts DJ; Hill MD; Holodinsky JK; Todd S; Kubes P; Wong JH
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1241-8. PubMed ID: 25853905
[TBL] [Abstract][Full Text] [Related]
13. The role of endogenous versus exogenous tPA on edema formation in murine ICH.
Thiex R; Mayfrank L; Rohde V; Gilsbach JM; Tsirka SA
Exp Neurol; 2004 Sep; 189(1):25-32. PubMed ID: 15296833
[TBL] [Abstract][Full Text] [Related]
14. Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages.
Goulay R; Naveau M; Gaberel T; Vivien D; Parcq J
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1180-1189. PubMed ID: 28741405
[TBL] [Abstract][Full Text] [Related]
15. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis using urokinase in severe ventricular haemorrhage.
Du B; Wang J; Zhong XL; Liang J; Xiang W; Chen D; Lv W; Shan AJ
Brain Inj; 2014; 28(11):1413-6. PubMed ID: 24830742
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis.
Staykov D; Kuramatsu JB; Bardutzky J; Volbers B; Gerner ST; Kloska SP; Doerfler A; Schwab S; Huttner HB
Ann Neurol; 2017 Jan; 81(1):93-103. PubMed ID: 27888608
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?
Abdelmalik PA; Ziai WC
Semin Respir Crit Care Med; 2017 Dec; 38(6):745-759. PubMed ID: 29262432
[TBL] [Abstract][Full Text] [Related]
18. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
[TBL] [Abstract][Full Text] [Related]
19. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.
Mayfrank L; Kissler J; Raoofi R; Delsing P; Weis J; Küker W; Gilsbach JM
Stroke; 1997 Jan; 28(1):141-8. PubMed ID: 8996503
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown.
Gurewich V
Cardiovasc Drugs Ther; 2019 Dec; 33(6):749-753. PubMed ID: 31897763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
